Callio Therapeutics logo

Callio Therapeutics

calliotx.com

Callio Therapeutics develops dual-payload antibody-drug conjugates (ADCs) for people with cancer, including patients with tumors that have developed resistance to existing therapies. Its platform pairs synergistic drug payloads and uses a proprietary linker to design targeted treatments intended to overcome resistance and deliver more durable responses.

Facts

HQ
Seattle, WA, USA
Sectors
Biotechnology Research
Founded
2025
Employees
24
Stage
Series A

Is this your organization? Claim it

Founders

  • Jerome Boyd-Kirkup Co-Founder
  • Piers Ingram Co-Founder

Executives

  • Chris Hassig Executive, Chief Scientific Officer
  • Kevin Hambly Executive, Chief Business Officer
  • Kiran Asarpota Executive, Chief Operating Officer
  • Meredith Wesley Executive, Chief Human Resources Officer
  • Naomi Hunder Executive, Chief Medical Officer
  • Zachary Hornby Executive, Chief Executive Officer

Online